ARPA-H collaborative forges partnerships to accelerate health outcomes | UTSA Today | UTSA

Meanwhile, the Investor Catalyst Hub, headquartered in the Greater Boston area, is leveraging researchers, entrepreneurs and investors to speed the transition of health care ideas into practical, accessible solutions, and a Stakeholder and Operations hub slated in or near the nation’s capital, will work with federal partners to bring these health care solutions to market.

Initial meetings

The Customer Experience Hub, established in fall 2023, has started working with research and academic institutions in San Antonio, Austin, Houston and around the state to explore collaborative opportunities.

This week many of the hub’s partners gathered in San Antonio for the inaugural ARPA-H Hub Workshop. The workshop provided an opportunities for partners from around Texas to learn more about their hub and how the partners will work together to make health care solutions more accessible and adoptable.

San Antonio alone is home to a $44 billion health care and biomedicine industry.

“It was energizing to meet with other members of the Customer Experience Hub this week and to explore how we can work together to accelerate projects that will change the way the United States delivers health care, particularly to diverse populations,” said JoAnn Browning, UTSA interim vice president of Research, Economic Development and Knowledge Enterprise. “We can see already the many opportunities available to leverage the innovation, intellectual curiosity and entrepreneurial spirit that drives our Texas hub.”

“As an environment that is known for its commitment to research and development, UTSA is well-positioned to make impactful contributions that help ARPA-H solve some of the most pressing challenging in human health,” Browning continued.

The Advancing Clinical Trial Readiness (ACTR) Initiative, which will focus on creating new clinical trials that are tailored to representative patient populations, was one of the key initiatives the partners explored this week.

The ACTR aims to enable 90% of all eligible Americans to take part in a clinical trial within a half hour of their home by working with groups across the country, including innovators, industry, patients, academia, hospital centers, community health centers, and non-traditional partners, such as retail pharmacies or home health innovators, to build faster, less expensive trials with decentralized processes.

The effort will also build trials that operate closer to, or at, points of care and are representative of the nation’s geography, age, gender, race, ethnicity, and socioeconomic groups.